What is Pseudohyperphosphatemia?
Pseudohyperphosphatemia is a laboratory artifact where serum phosphate levels are falsely elevated due to analytical interference, most commonly caused by monoclonal immunoglobulins (paraproteins) in patients with gammopathies, but also by hyperlipidemia, hyperbilirubinemia, hemolysis, or contamination with phosphate-containing solutions.
Mechanism and Causes
The spurious elevation occurs because certain substances interfere with the phosphomolybdate colorimetric assay used by many automated analyzers to measure inorganic phosphate 1. The true serum phosphate level is actually normal, but the measurement is artifactually elevated.
Primary Causes:
Paraproteinemia (Most Common)
- Monoclonal immunoglobulins from multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), or Waldenström macroglobulinemia interfere with phosphate assays 2, 3
- Both IgG and IgA paraproteins can cause this phenomenon 4
- The degree of elevation correlates with both the concentration and physicochemical characteristics of the abnormal globulin 5
- Critical clinical pearl: An unexplained persistent hyperphosphatemia may be the first clue to an underlying gammopathy 3
Other Documented Causes:
- Severe hyperlipidemia 1, 2
- Hyperbilirubinemia 1, 2
- Hemolysis 2
- Liposomal amphotericin B exposure 1
- Pre-analytical contamination: Blood samples drawn from hemodialysis catheters containing concentrated heparin or alteplase (rt-PA) solutions, which have extremely high phosphorus content 6
Clinical Recognition
When to Suspect Pseudohyperphosphatemia:
- Elevated phosphate levels that are clinically unexplained and inconsistent with the patient's overall presentation
- Absence of typical causes of true hyperphosphatemia (renal failure, hypoparathyroidism, tumor lysis syndrome, excessive phosphate intake)
- Patient has known or suspected paraproteinemia
- Patient on hemodialysis with samples drawn from central venous catheters
- Persistent hyperphosphatemia without corresponding clinical manifestations
Diagnostic Confirmation
To confirm pseudohyperphosphatemia, perform one or more of the following:
Protein removal techniques: Measure phosphate after sulfosalicylic acid precipitation or ultrafiltration of serum—this normalizes the falsely elevated values 3, 5
Serial dilutions: Progressive dilution of the sample should normalize phosphate levels if interference is present 7
Alternative assay method: Use a different analytical platform (e.g., ORTHO VITROS assay) that is free from monoclonal gammaglobulin interference 7
Evaluate for paraproteinemia: Order serum protein electrophoresis, immunofixation, and serum free light chain ratio if not already done 7
Clinical Implications and Pitfalls
Critical Management Points:
- Do not treat pseudohyperphosphatemia with phosphate binders—this exposes patients to unnecessary medications and potential adverse effects 5
- Recognize that IgA paraproteins may be missed on routine protein electrophoresis because they migrate to the beta-globulin region rather than forming a sharp M-spike in the gamma region 4
- For hemodialysis patients, ensure adequate flushing of catheters before blood sampling to avoid contamination with phosphate-rich lock solutions 6
- The finding of pseudohyperphosphatemia can prompt investigation that leads to diagnosis of previously unrecognized gammopathies, including progression from smoldering to symptomatic multiple myeloma 7
Laboratory Communication:
Both clinical biochemists and clinicians must be aware of this phenomenon to avoid diagnostic confusion, unnecessary testing, and inappropriate treatment 2. When pseudohyperphosphatemia is suspected, direct communication between the ordering clinician and laboratory is essential to arrange confirmatory testing.